A correction to this paper has been published and can be accessed via a link at the top of the paper.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643148PMC
http://dx.doi.org/10.1038/s41408-020-00374-3DOI Listing

Publication Analysis

Top Keywords

correction imatinib
4
imatinib mesylate
4
mesylate inhibits
4
inhibits stat5
4
stat5 phosphorylation
4
phosphorylation response
4
response il-7
4
il-7 promotes
4
promotes cell
4
cell lymphopenia
4

Similar Publications

Two different mutational types of familial gastrointestinal stromal tumors: Two case reports.

World J Gastrointest Oncol

September 2024

Department of General Surgery, Gansu Provincial Hospital, Lanzhou 730000, Gansu Province, China.

Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract, and cases of GISTs tend to be of the disseminated type, with a global incidence of 10 to 15 cases/million each year. The rarer familial GISTs, which often represent a population, differ in screening, diagnosis, and treatment. Familial GISTs include primary familial GISTs with predominantly KIT/PDGFRA mutations and wild-type GISTs.

View Article and Find Full Text PDF
Article Synopsis
  • Medication-related osteonecrosis of the temporal bone is uncommon and linked to certain medications, specifically anti-resorptive and tyrosine-kinase inhibitors, with new cases being reported.* -
  • Three case studies highlight patients with osteonecrosis of the external auditory canal (EAC), with treatments ranging from conservative management to surgical reconstruction, showing varying success.* -
  • The findings suggest that these medications can disrupt bone remodeling, and when standard therapies fail, surgical intervention may be necessary for symptom relief.*
View Article and Find Full Text PDF

Mechanisms and treatment of pulmonary arterial hypertension.

Nat Rev Cardiol

August 2024

Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI), German Center for Lung Research (DZL), Giessen, Germany.

Article Synopsis
  • Significant advancements in the management of pulmonary arterial hypertension (PAH) have been made over the last 25 years, but the condition still limits life expectancy.
  • Traditional PAH treatments mainly provide symptom relief and involve balancing vasoactive factors, while newer drugs like imatinib show promise but come with potential side effects.
  • Innovative treatments such as inhaled tyrosine kinase inhibitors and sotatercept are in development, with a focus on improving patient outcomes and personalized medicine for better management of the disease.
View Article and Find Full Text PDF

Acute myeloid leukemia with fusion gene: 'Pitfalls' in diagnosis.

Hematology

December 2024

Department of Clinical Laboratory, Fuyang People's Hospital, Fuyang, People's Republic of China.

Article Synopsis
  • The text discusses a rare case of acute myeloid leukemia (AML) associated with basophilia, emphasizing the challenges in diagnosing this condition due to its rarity and poor prognosis.
  • The authors describe their use of various diagnostic methods, including morphological screening, immunotyping, FISH analysis, and RNA sequencing, to accurately identify the type of AML and to guide treatment decisions.
  • The study highlights the importance of advanced techniques such as NGS for detecting a broader range of genetic mutations, which can help avoid misdiagnosis and improve treatment outcomes for patients with hematologic malignancies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!